Loading...
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)
Background: The therapeutic paradigm of metastatic urothelial carcinoma (UC) is rapidly shifting and new biomarkers are needed to enhance patient selection. Objective: Early identification of dynamic predictors of outcome may be a key to optimize the sequence of effective therapies in metastatic UC...
Na minha lista:
| Udgivet i: | Bladder Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IOS Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5181661/ https://ncbi.nlm.nih.gov/pubmed/28035320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-160069 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|